A trend toward more conservative surgery in gynecologic oncology

Obstetrical and Gynecological Survey

Volumn 51, Issue 10, 1996, Pages 628-636

  Menczer, J ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CYSTECTOMY; ENDOMETRIUM CARCINOMA; FEMALE; GYNECOLOGIC CANCER; HUMAN; HYSTERECTOMY; LAPAROTOMY; LYMPHADENECTOMY; ORGAN PRESERVATION; OVARY CARCINOMA; REVIEW; SECOND LOOK SURGERY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CONIZATION; VULVA CARCINOMA;

CARCINOMA; CARCINOMA, SQUAMOUS CELL; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGY; HUMANS; MEDICAL ONCOLOGY; OVARIAN NEOPLASMS; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 0029837356     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199610000-00023     Document Type: Review

References (142)

1. Taussig FJ. Cancer of the vulva: An analysis of 155 cases (1911-1940). Am J Obstet Gynecol 1949;40:764-772.
2. Way S. Carcinoma o the vulva. Am J Obstet Gynecol 1960; 78:692-697.
3. Morley GW. Infiltrative carcinoma of the vulva: Results of surgical treatment. Am J Obstet Gynecol 1976;874-879.
4. Way S, Hannigan M. The late results of extended vulvectomy for carcinoma of the vulva. J Obstet Gyncol Br Commonw 1966;73:594-598.
5. Rutledge F, Smith J, Franklin EW. Carcinoma of the vulva. Am J Obstet Gynecol 1970;124:874-888.
6. Andersen BL, Hacker NF. Psychosexual adjustment after vulvar surgery. Obstet Gynecol 1983;62:457-462.
7. Goldberg MI, Belinson JL, Ford JH. Surgical management of invasive carcinoma of the vulva utilizing a lower abdominal midline incision. Gynecol Oncol 1979;7:296-301.
8. Lifshitz S, Buchsbaum HJ. Pigskin xenograft as biologic dressing in radical vulvectomy. Obstet Gynecol 1984;63: 434-436.
9. Byron RL, Mishell DR, Yonemoto RM. The surgical treatment of invasive carcinoma of the vulva. Surg Gynecol Obstet 1965;121:1243-1248.
10. DiSaia PJ. The case against the surgical concept of en-bloc dissection for certain malignancies of the reproductive tract. Cancer 1987;60:2025-2034.
11. Gleeson NC, Hoffman MS, Cavanagh D. Isolated skin bridge metastasis following modified radical vulvectomy and bilateral inguinofemoral lymphadenectomy. Int J Gynecol Cancer 1994;4:356-358.
12. Ballon SC, Lamb EJ. Separate incisions in the treatment of carcinoma of the vulva. Surg Gynecol Obstet 1975;140:81-84.
13. Hacker NF, Leuchter RS, Berek JS et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 1981;58:574-579.
14. Grimshaw RN, Murdoch JB, Monaghan JM. Radical vulvectomy and bilateral inguinal-femoral lymphadenectomy through separate incisions: Experience with 100 cases. Int J Gynecol Cancer 1993;3:18-23.
15. Monaghan JM, Hammond IG. Pelvic node dissection in the treatment of vulval carcinoma. Is it necessary? Br J Obstet Gynaecol 1984;91:270-274.
16. Podratz KC, Symmonds RE, Taylor WF. Carcinoma of the vulva: Analysis of treatment failures. Am J Obstet Gynecol 1982;143:340-344.
17. Franklin EW, Rutledge FD. Prognostic factors in epidermoid carcinoma of the vulva. Obstet Gynecol 1971;37:892-901.
18. Homesley HD, Bundy BN, Sedlis A et al. Radiation therapy versus node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986;68:733-740.
19. Iversen T, Ras M. Lymph drainage from the vulva. Gynecol Oncol 1983;16:179-189.
20. DiSaia PJ, Creasman WT, Rich W. An alternative approach to early cancer of the vulva. Am J Obstet Gynecol 1979;133: 825-830.
21. Berman ML, Soper JT, Creasman WT et al. Conservative surgical management of superficially invasive stage I vulvar carcinoma. Gynecol Oncol 1989;35:352-357.
22. Burke TW, Stringer CA, Gershenson DM et al. Radical wide excision and selective lymph node dissection for squamous carcinoma of the vulva. Gynecol Oncol 1990;38:328-332.
23. Atamdede F, Hoogerland D. Regional lymph node recurrence following local excision for microinvasive vulvar carcinoma. Gynecol Oncol 1989;34:125-128.
24. Van der Velden J, Kooyman CD, Van Lindert ACM et al. A stage I vulvar carcinoma with an inguinal lymph node recurrence after local excision. A case report and literature review. Int J Gynecol Cancer 1992;2:157-159.
25. Andrews SJ, Wiliams BT, DePriest PD et al. Therapeutic implications of lymph nodal spread in lateral T1 and T2 squamous cell carcinoma of the vulva. Gynecol Oncol 1994; 55:41-46.
26. Burrell MO, Franklin EW, Campion MD. The modified radical vulvectomy with groin dissection. An eight-year experience. Am J Obstet Gynecol 1988;159:715-719.
27. Farias-Eisner R, Lirisand FD, Brause D et al. Conservative and individualized surgery for early squamous carcinoma of the vulva: Treatment of choice for stage I and II (T1-2 N0-1 MO) disease. Gynecol Oncol 1994;53:55-58.
28. Iversen T, Abeler V, Raiders V. Individualized treatment of stage I carcinoma of the vulva. Obstet Gynecol 1981;57:85-89.
29. Wharton JT, Gallagher S, Rutledge FM. Microinvasive carcinoma of the vulva. Am J Obstet Gynecol 1974;118:159-162.
30. Parker RT, Duncan I, Rampone J et al. Operative management of early invasive epidermoid carcinoma of the vulva. Am J Obstet Gynecol 1975;123:349-355.
31. Nakao CY, Nolan JF, DiSaia PJ et al. "Microinvasive" epidermoid carcinoma of the vulva with an unexpected natural history. Am J Obstet Gynecol 1974;120:1122-1123.
32. Hacker NF, Nieberg RK, Berek JS et al. Superficial invasive vulvar cancer with nodal metastases. Gynecol Oncol 1983; 15:65-77.
33. Sedlis A, Homesley H, Bundy BN et al. Positive groin lymph nodes in superficial squamous cell vulvar cancer. A Gynecologic Oncology Group Study. Am J Obstet Gynecol 1987; 156:1159-1164.
34. Kneale BL, Announcement. Gynecol Oncol 1984;18:134.
35. Hoffman JS, Kumar NB, Morley GW. Microinvasive squamous carcinoma of the vulva: Search for a definition. Obstet Gynecol 1983;61:615-618.
36. Boyce CR, Seraj IM, Thrasher T et al. Microinvasive squamous carcinoma of the vulva: Present status and reassessment. Gynecol Oncol 1984;8:71-76.
37. Hacker NF, Berek JS, Lagasse CD et al. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 1984;63:155-162.
38. Kelley JL, Burke TW, Tornos C et al. Minimally invasive vulvar carcinoma: An indication for conservative surgical therapy. Gynecol Oncol 1992;44:240-244.
39. Thomas G, Dembo A, DePetrillo A et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 1989;34:263-267.
40. Hacker NF, Berek JS, Juillard GJF et al. Preoperative radiation therapy for locally advanced vulvar cancer. Cancer 1984;54:2056-2061.
41. Sebag-Montefiore DJ, McLean C, Arnott SJ et al. Treatment of advanced carcinoma of the vulva with chemoradiotherapy - Can exenterative surgery be avoided? Int J Gynecol Cancer 1994;4:356-358.
42. Boronow RC, Hickman BT, Reagan MT et al. Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. Am J Clin Oncol 1987;10:171-181.
43. Thomas GM, Dembo AJ, Bryson SCP et al. Changing concepts in the management of vulvar cancer. Gynecol Oncol 1991;42:9-21.
44. DiSaia PJ. The cervix. In: Romney SL, Gray MJ, Little AB et al., eds. Gynecology and Obstetrics: The Health Care of Women. New York: McGraw-Hill; 1981, pp 1015-1052.
45. Gusberg SB. Cancer of the cervix: Cancer in situ and pathogenesis. In: Gusberg SB, Frick HC, eds. Corscaden's Gynecologic Cancer. Baltimore, MD: Williams & Wilkins: 1978, pp 130-151.
46. Goodwin JS, Hunt WC, Key CR et al. Changes in surgical treatments. The example of hysterectomy versus conization for cervical carcinoma in situ. J Clin Epidemiol 1990;43:977-982.
47. Prenderville W, Gillimore J, Norman S. Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intraepithelial neoplasia. Br J Obstet Gynecol 1986;96:1054-1060.
48. Wagner AL. Laser excisional conization in an office environment. J Gynecol Surg 1990;6:47-51.
49. Mor-Yosef S, Lopez A, Pearson S et al. Loop diatherapy cone biopsy. Obstet Gynecol 1990;78:884-886.
50. Albrechtsen R, Koch F. Prognostic accuracy of cervical cone biopsy. Prediction of complete or incomplete removal of cervical carcinoma in situ. Dan Med Bull 1972;19:119.
51. Burghart E, Holzer E. Treatment of carcinoma in situ: Evaluation of 1609 cases. Obstet Gynecol 1980;55:539.
52. 2 laser. Am J Obstet Gynecol 1989;161:60.
53. Hesseinzadeh N, Shbaro I, Wesseler T. Predictive value of cone margins and postcone endocervical curettage with residual disease in subsequent hysterectomy. Gynecol Oncol 1989;33:198-200.
54. Pearson SE, Whittaker J, Ireland D et al. Invasive cancer of the cervix after laser treatment. Br J Obstet Gynaecol 1989; 96:486-488.
55. Brown JV, Peters WA, Corwin DJ. Invasive carcinoma after cone biopsy for cervical intraepithelial neoplasia. Gynecol Oncol 1991;40:25-28.
56. Shumsky AG, Stuart GCE, Nation J. Carcinoma of the cervix following conservative management of cervical intraepithelial neoplasia. Gynecol Oncol 1994;53:50-54.
57. Van Nagell JR, Greenwell N, Powell DJ et al. Microinvasive carcinoma of the cervix. Am J Obstet Gynecol 1983;145: 981-991.
58. Seski JC, Abell MR, Morley GW. Microinvasive squamous carcinoma of the cervix. Obstet Gynecol 1977;50:410-414.
59. Creasman WT, Fetter BF, Clarke Pearson DL et al. Management of stage IA carcinoma of the cervix. Am J Obstet Gynecol 1985;153:164-172.
60. Kolstad P. Follow-up study of 232 patients with stage IA, and 411 patients with stage IA2 squamous cell carcinoma of the cervix. Gynecol Oncol 1989;33:265-272.
61. Morris M, Mitchell MF, Silva EG et al. Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecol Oncol 1993;51:193-196.
62. Ueki M, Okamoto Y, Misaki O et al. Conservative therapy for microinvasive carcinoma of the uterine cervix. Gynecol Oncol 1994;53:109-113.
63. Burghardt E, Holzer E. Diagnosis and treatment of microinvasive carcinoma of the cervix uteri. Obstet Gynecol 1977; 49:641-653.
64. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-272.
65. Jakobsen A, Bichel P, Ahrons S et al. Is radical hysterectomy always necessary in early cervical cancer? Gynecol Oncol 1990;39:80-81.
66. Sardi J, Sananes C, Giaroli A et al. Is subradical surgical treatment for carcinoma of the cervix uteri stage IB logical? Gynecol Oncol 1989;32:360-364.
67. Rutledge FN, Smith JP, Wharton JT et al. Pelvic exenteration: An analysis of 296 patients. Am J Obstet Gynecol 1977;129: 881-892.
68. Lowhead RA Jr, Clark DGC, Smith DH. Pelvic exenteration for recurrent or persistent gynecologic malignancies: A 10-year review of the Memorial Sloan Kettering Cancer Center experience (1972-1981). Gynecol Oncol 1989;33:279-282.
69. Morley GW, Hopkins MP, Lindenauer SM et al. Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 1989;74:934-943.
70. Rubin SC, Hoskins WJ, Lewis JL Radical hysterectomy for recurrent cervical cancer therapy following radiation therapy. Gynecol Oncol 1987;27:316-322.
71. Rutledge S, Carey MS, Prichard H et al. Conservative surgery for recurrent or persistent carcinoma of the cervix following irradiation: Is exenteration always necessary? Gynecol Oncol 1994;52:353-359.
72. Chen SS, Lee L. Retroperitoneal lymph node metastases in stage I carcinoma of the endometrium: Correlation with risk factors. Gynecol Oncol 1983;16:319-325.
73. Boronow RC, Morrow CP, Creasman WT et al. Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825-832.
74. DiSaia PJ, Creasman WT, Borronow RC et al. Risk factors and recurrent patterns in stage I endometrial carcinoma. Am J Obstet Gynecol 1984;151:1009-1015.
75. Creasman WT, Morrow P, Bundy B et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecological Oncology Group study. Cancer 1987;60:2035-2041.
76. FIGO. Classification and staging of malignant tumors in the female pelvis. Int J Gynecol Obstet 1971;9:172-175.
77. FIGO News. Corpus cancer staging. Int J Gynaecol Obstet 1989;28:190.
78. Vardi JR, Tadros GH, Anselmo MT et al. The value of exploratory laparotomy in patients with endometrial carcinoma according to the new International Federation of Gynecology and Obstetrics staging. Obstet Gynecol 1992;40:204-208.
79. Wolfson AH, Sightler SE, Markoe AM et al. The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol 1992;45:142-146.
80. Gal D, Recio FO, Zamurovic D. The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinoma. Cancer 1992; 69:200-202.
81. Larson OM, Johnson KK. Pelvic and paraaortic lymphadenectomy for surgical staging of high-risk endometrioid adenocarcinoma of the endometrium. Gynecol Oncol 1993;51: 345-348.
82. Blythe JG, Hodel KA, Wahl TP et al. Paraaortic node biopsy in cervical and endometrial cancers: Does it affect survival? Am J Obstet Gynecol 1986;155:306-314.
83. Corn BW, Lanciano RM, Greven KM et al. Endometrial cancer with paraaortic adenopathy: Patterns of failure and opportunities for cure. Int J Radiat Oncol Biol Phys 1992;24: 223-227.
84. Belinson JL, Lee KR, Badger GJ et al. Clinical stage I adenocarcinoma of the endometrium - Analysis of recurrences and potential benefit of staging lymphadenectomy. Gynecol Oncol 1992;44:17-23.
85. Kim YB, Nilloff JM. Endometrial carcinoma: Analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy. Obstet Gynecol 1993; 82:175-180.
86. Girardi F, Petru E, Heydarfadai MM et al. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol 1993;49:177-180.
87. Chen SS, Rumanick WM, Spregel G. Magnetic resonance imaging in stage I endometrial cancer. Obstet Gynecol 1990; 75:274-277.
88. Sahakian V, Syrop C, Turner D. Endometrial carcinoma: Transvaginal ultrasonography prediction of depth of myometrial invasion. Gynecol Oncol 1991;43:217-219.
89. Malviya VK, Deppe G, Malone JM Jr et al. Reliability of frozen section examination in identifying poor prognostic indicators in stage I endometrial adenocarcinoma. Gynecol Oncol 1989;34:299-304.
90. Fanning J, Tsukada Y, Piver MS. Intraoperative frozen section diagnosis of depth of myometrial invasion. Gynecol Oncol 1990;37:47-50.
91. Faught W, Krepart GV, Lotocki R et al. Should selective paraaortic lymphadenectomy be part of surgical staging for endometrial cancer? Gynecol Oncol 1994;55:51-55.
92. Julian CG, Woodruff JD. The biological behavior of low-grade papillary serous carcinoma of the ovary. Obstet Gynecol 1972;40:860-867.
93. Barnhill D, Heller P, Brzozowski P et al. Epithelial ovarian carcinoma of low malignant potential. Obstet Gynecol 1985; 65:53-58.
94. Tasker M, Langley FA. The outlook for women with borderline epithelial tumors of the ovary. Br J Obstet Gynaecol 1985;92:969-973.
95. Bostwick DG, Tazelaar HD, Ballon SC et al. Ovarian epithelial tumors of borderline malignancy: A clinical and pathologic study of 109 cases. Cancer 1986;58:2052-2065.
96. Kliman L, Rome RM, Fortune DW. Low malignant potential tumors of the ovary: A study of 76 cases. Obstet Gynecol 1986;68:338-344.
97. Chambers JT, Merino MJ, Kohorn EI et al. Borderline ovarian tumors. Am J Obstet Gynecol 1988;159:1088-1094.
98. Leake JF, Currie JL, Rosenshein NB et al. Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 1992;47:150-158.
99. Creasman WT, Park R, Norris H et al. Stage I borderline ovarian tumors. Obstet Gynecol 1982;59:93-96.
100. Tazelaar HD, Bostwick DG, Ballon SC et al. Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985;66:417-422.
101. Rice LW, Berkowitz RS, Mark SD et al. Epithelial tumors of borderline malignancy. Gynecol Oncol 1990;39:195-198.
102. Bell DA, Scully RE. Ovarian serous borderline tumors with stromal microinvasion: A report of 21 cases. Hum Pathol 1990;21:397-403.
103. Robinson WR, Curtin JP, Morrow CP. Operative staging and conservative surgery in the management of low malignant potential ovarian tumors. Int J Gynecol Cancer 1992;2:113-118.
104. Dire F, Paladini D, Fontanelli R et al. Surgical staging for epithelial ovarian tumors of low malignant potential. Int J Gynecol Cancer 1994;4:319-314.
105. Young RC, Decker DG, Wharton JT et al. Staging laparotomy in early ovarian cancer. J Am Med Assoc 1983;250:3072-3076.
106. Helewa ME, Krepart GV, Lotocki R. Staging laparotomy in early epithelial ovarian carcinoma. Am J Obstet Gynecol 1986;154:282-286.
107. Yazigi R, Sandstad J, Munoz AL. Primary staging in ovarian tumors of low malignant potential. Gynecol Oncol 1988;31: 40.
108. Leake JF, Rader JJ, Woodruff SD et al. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1991;42:124-130.
109. Hopkins MP, Morley GW. The second-look operation and surgical re-exploration in ovarian tumor of low malignant potential. Obstet Gynecol 1989;74:375-378.
110. Snider DD, Stuart GC, Nation JG et al. Evaluation of surgical staging in stage I low malignant potential ovarian tumors. Gynecol Oncol 1991;40:129-132.
111. Nation JG, Krepart GV. Ovarian carcinoma of low malignant potential: Staging and treatment. Am J Obstet Gynecol 1986;154:290-293.
112. O'Quinn AG, Hannigan EV. Epithelial ovarian neoplasm of low malignant potential. Gynecol Oncol 1985;21:177-185.
113. Fort MG, Pierce VK, Saigo PE et al. Evidence for efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1989;32:269-272.
114. Bell DA, Weinstock MA, Scully RE. Peritoneal in plants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer 1988;62:2212-2222.
115. Piura B, Dgani R, Blickstein I et al. Epithelial ovarian tumors of borderline malignancy: A study of 50 cases. Int J Gynecol Cancer 1992;2:189-197.
116. Lim-Tan SK, Cajigas HB, Scully RE. Ovarian cystectomy for serous borderline tumors: A follow-up study of 35 cases. Obstet Gynecol 1988;72:775-780.
117. DiSaia PJ, Townsend DE, Morrow CP. The rationale for less than radical treatment of gynecologic malignancy in the reproductive years. Obstet Gynecol Surv 1979;29: 581-590.
118. Ozols O, Rubin SC, Dembo AJ. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology. Philadelphia: JB Lippincott, 1992, pp 731-781.
119. Piver MS, Baker T. The potential for optimal (≤2 cm) cytoreductive surgery in advanced carcinoma at a tertiary medical center. A prospective study. Gynecol Oncol 1986;24:1-9.
120. Heinz APM, Hacker NF, Berek JS et al. Cytoreductive surgery in ovarian carcinoma. Feasibility and morbidity. Obstet Gynecol 1986;67:783-789.
121. Griffiths CT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975;42:101-108.
122. Delgado G, Oram DH, Petrilli ES. Stage III epithelial ovarian cancer. The role of maximal surgical reduction. Gynecol Oncol 1984;18:293-299.
123. Redman JR, Petroni GR, Saigo PE et al. Prognostic factors in advanced ovarian carcinoma. J Clin Oncol 1986;4:515-522.
124. Heintz APM. Surgery in advanced ovarian carcinoma. Is there proof to show the benefit? Eur J Surg Oncol 1988;14: 91-96.
125. Menczer J. Cytoreductive surgery in the treatment of advanced ovarian carcinoma. Some controversial aspects. Eur J Gynecol Oncol 1992;13:246-255.
126. Krag KJ, Canellos GP, Grifiths CT. Predictive factors for long-term survival in patients with advanced ovarian cancer. Gynecol Oncol 1989;34:88-93.
127. Schwartz PE, Chambers JT, Kohorn EI. Tamoxifen in combination chemotherapy with cytotoxic chemotherapy in advancer ovarian cancer: A prospective randomized trial. Cancer 1989;63:1074-1078.
128. Hoskins DJ, O'Reilly SE, Swenerton KD. Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy. J Clin Oncol 1992;10:1561-1568.
129. Hunter RW, Alexander NDE, Sutler WP. Meta-analysis of surgery in advanced ovarian carcinoma: Is maximum cytoreductive surgery an independent determinant of prognosis. Am J Obstet Gynecol 1992;166:504-511.
130. Potter ME, Partridge EE, Hatch KD et al. Primary surgical therapy of ovarian cancer: How much and when? Gynecol Oncol 1991;40:195-200.
131. Piver MS, Lele SB, Marchetti DL et al. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. J Clin Oncol 1988;6:983-989.
132. Berek JS, Hacker NF, Lagasse LD et al. Lower urinary tract resection as part of cytoreductive surgery for ovarian cancer. Gynecol Oncol 1982;13:87-92.
133. Hoskins WJ, Bundy BL, Thigpen JT et al. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group Study. Gynecol Oncol 1992; 47:159-166.
134. Guidozzi F, Ball JHS. Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 1994;53:326-330.
135. Morris M, Gershenson DM, Wharton JT et al. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Gynecol Oncol 1989;34:334-339.
136. Schwartz PE, Chambers JT, Makuch R. Neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol 1994;53:33-37.
137. Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 1993;11:166-172.
138. Gallup DG, Talledo OE, Dudzinski MR et al. Another look at the second-assessment procedure for ovarian epithelial carcinoma. Am J Obstet Gynecol 1987;157:590-596.
139. Young RC. A second look at second-look laparotomy. J Clin Oncol 1987;5:1311-1313.
140. Friedman JB, Weiss NS. Second thoughts about second-look laparotomy in advanced ovarian cancer. N Engl J Med 1991;322:1079-1081.
141. Berek JS. Second-look versus second nature. Gynecol Oncol 1992;44:1-2.
142. Potter ME, Hatch KD, Soong SJ et al. Second-look laparotomy and salvage therapy: A research modality only? Gynecol Oncol 1992;44:3-9.